EVE
vs
S
S&P/ASX 300
EVE
Over the past 12 months, EVE has underperformed S&P/ASX 300, delivering a return of -50% compared to the S&P/ASX 300's +9% growth.
Stocks Performance
EVE vs S&P/ASX 300
Performance Gap
EVE vs S&P/ASX 300
Performance By Year
EVE vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Eve Health Group Ltd
Glance View
EVE Health Group Ltd. engages in the investment in technology companies. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2004-04-08. The firm is engaged in agricultural operations located in northern New South Wales and the Meluka Honey business. The firm operates through two segments: Agriculture and Investment. The Company’s businesses include Meluka Australia Pty Ltd, Jenbrook Australia, Naturally Australian Products Inc. and Omni Innovation Pty Ltd. Meluka Health Pty Ltd provides retail health and wellness consumer products, including honey. Jenbrook Australia is a producer of organic tea tree and distributor of Australian botanical oils. Naturally Australian Products Inc. is a wholesaler of native Australian essential oils. Omni Innovation Pty Ltd. provides medical nutrition solutions for chronic and lifestyle diseases. The firm offers various products, including Raw Honey Probiotic Concentrate, Premium Tea Tree Essential Oil and organic honey products.